In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease

Neurology

Volumn 63, Issue 6, 2004, Pages 989-995

  Fennema Notestine, Christine ^a,b,d   Archibald, S L ^a,b   Jacobson, M W ^a,b   Corey Bloom, J ^c   Paulsen, J S ^e   Peavy, G M ^c   Gamst, A C ^c,d   Hamilton, J M ^c   Salmon, D P ^c   Jernigan, T L ^a,b  

^a Vet Aff S Diego Healthcare System   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; BASAL GANGLION; BRAIN CORTEX; CEREBELLUM; CEREBELLUM ATROPHY; CLINICAL ARTICLE; EDUCATION; HUMAN; HUNTINGTON CHOREA; MORPHOMETRICS; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; WHITE MATTER;

EID: 4644245086     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000138434.68093.67     Document Type: Article

References (33)

1. Gusella JF, Wexler NS, Conneally PM, et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 1983;306:234-238.
2. Huntington's Disease Collaborative Research Group T. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 1993;72:971-983.
3. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP, Jr. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985;44:559-577.
4. Young AB, Penney JB, Starosta-Rubinstein S, et al. PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline. Ann Neurol 1986;20:296-303.
5. Kuwert T, Lange HW, Langen KJ, Herzog H, Aulich A, Feinendegen LE. Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. Brain 1990;113(Pt 5):1405-1423.
6. Jernigan TL, Salmon DP, Butters N, Hesselink JR. Cerebral structure on MRI, part II: specific changes in Alzheimer's and Huntington's diseases. Biol Psychiatry 1991;29:68-81.
7. Hasselbalch SG, Oberg G, Sorensen SA, et al. Reduced regional cerebral blood flow in Huntington's disease studied by SPECT. J Neurol Neurosurg Psychiatry 1992;55:1018-1023.
8. Harris GJ, Aylward EH, Peyser CE, et al. Single photon emission computed tomographic blood flow and magnetic resonance volume imaging of basal ganglia in Huntington's disease. Arch Neurol 1996;53:316-324.
9. Sax DS, Powsner R, Kim A, et al. Evidence of cortical metabolic dysfunction in early Huntington's disease by single-photon-emission computed tomography. Mov Disord 1996;11:671-677.
10. Aylward EH, Li Q, Stine OC, et al. Longitudinal change in basal ganglia volume in patients with Huntington's disease. Neurology 1997;48:394-399.
11. Oyanagi K, Takeda S, Takahashi H, Ohama E, Ikuta F. A quantitative investigation of the substantia nigra in Huntington's disease. Ann Neurol 1989;26:13-19.
12. de la Monte SM, Vonsattel JP, Richardson EP, Jr. Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J Neuropathol Exp Neurol 1988;47:516-525.
13. Mann DM, Oliver R, Snowden JS. The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy. Acta Neuropathol (Berl) 1993;85:553-559.
14. Bruyn GW, von Wolferen WJ. Pathogenesis of Huntington's chorea. Lancet 1973;1:1382.
15. Tellez-Nagel I, Johnson AB, Terry RD. Studies on brain biopsies of patients with Huntington's chorea. J Neuropathol Exp Neurol 1974;33:308-332.
16. Sotrel A, Paskevich PA, Kiely DK, Bird ED, Williams RS, Myers RH. Morphometric analysis of the prefrontal cortex in Huntington's disease. Neurology 1991;41:1117-1123.
17. Martin WR, Clark C, Ammann W, Stoessl AJ, Shtybel W, Hayden MR. Cortical glucose metabolism in Huntington's disease. Neurology 1992;42:223-229.
18. Jackson M, Gentleman S, Lennox G, et al. The cortical neuritic pathology of Huntington's disease. Neuropathol Appl Neurobiol 1995;21:18-26.
19. Aylward EH, Anderson NB, Bylsma FW, et al. Frontal lobe volume in patients with Huntington's disease. Neurology 1998;50:252-258.
20. Halliday GM, McRitchie DA, Macdonald V, Double KL, Trent RJ, McCusker E. Regional specificity of brain atrophy in Huntington's disease. Exp Neurol 1998;154:663-672.
21. 18)F]FDG PET study. J Nucl Med 2001;42:1591-1595.
22. Rosas HD, Liu AK, Hersch S, et al. Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology 2002;58:695-701.
23. Rosas HD, Koroshetz WJ, Chen YI, et al. Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 2003;60:1615-1620.
24. Vonsattel JP, DiFiglia M. Huntington disease. J Neuropathol Exp Neurol 1998;57:369-384.
25. Briley DP, Wasay M, Sergent S, Thomas S. Cerebral white matter changes (leukoaraiosis), stroke, and gait disturbance. J Am Geriatr Soc 1997;45:1434-1438.
26. Stout JC, Jernigan TL, Archibald SL, Salmon DP. Association of dementia severity with cortical gray matter and abnormal white matter volumes in dementia of the Alzheimer type. Arch Neurol 1996;53:742-749.
27. Huntington Study Group. Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group. Mov Disord 1996;11:136-142.
28. Jernigan TL, Archibald SL, Fennema-Notestine C, et al. Effects of age on tissues and regions of the cerebrum and cerebellum. Neurobiol Aging 2001;22:581-594.
29. Sapp E, Penney J, Young A, Aronin N, Vonsattel JP, DiFiglia M. Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease. J Neuropathol Exp Neurol 1999;58:165-173.
30. Aronin N, Chase K, Young C, et al. CAG expansion affects the expression of mutant Huntingtin in the Huntington's disease brain. Neuron 1995;15:1193-1201.
31. Sapp E, Schwarz C, Chase K, et al. Huntingtin localization in brains of normal and Huntington's disease patients. Ann Neurol 1997;42:604-612.
32. Sapp E, Kegel KB, Aronin N, et al. Early and progressive accumulation of reactive microglia in the Huntington disease brain. J Neuropathol Exp Neurol 2001;60:161-172.
33. Myers RH, Vonsattel JP, Paskevich PA, et al. Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus. J Neuropathol Exp Neurol 1991;50:729-742.